Suchergebnisse - Isabelle Carletti

  • Treffer 1 - 5 von 5
Treffer weiter einschränken
  1. 1
    Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination

    Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at le... von Geert Leroux‐Roels, Pascale Van Belle, Pierre Vandepapelière, Yves Horsmans, Michel Janssens, Isabelle Carletti, Nathalie Garçon, Martine Wettendorff, Marcelle Van Mechelen

    Veröffentlicht 2014
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Comparison of the immunogenicity and safety of<i>Cervarix</i>™ and<i>Gardasil</i><sup>®</sup>human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years

    Comparison of the immunogenicity and safety of<i>Cervarix</i>™ and<i>Gardasil</i><sup>®</sup>human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years... von Mark H. Einstein, Mira Baron, Myron J. Levin, Archana Chatterjee, Robert P. Edwards, Fred Zepp, Isabelle Carletti, Francis Dessy, Andrew F. Trofa, Anne Schuind, Gary Dubin

    Veröffentlicht 2009
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  3. 3
    An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers

    An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers von Eva Van Braeckel, Patricia Bourguignon, Marguerite Koutsoukos, Frédéric Clément, Michel Janssens, Isabelle Carletti, Alix Collard, Marie‐Ange Demoitié, Gérald Voss, Geert Leroux‐Roels, Lisa McNally

    Veröffentlicht 2011
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  4. 4
    A Phase II, Randomized, Safety and Immunogenicity Study of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults

    A Phase II, Randomized, Safety and Immunogenicity Study of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults von Stephen J. Thomas, Kenneth H. Eckels, Isabelle Carletti, Rafael De La Barrera, Francis Dessy, Stefan Fernandez, Robert Putnak, Jean‐François Toussaint, Wellington Sun, Kristen M. Bauer, Robert V. Gibbons, Bruce L. Innis

    Veröffentlicht 2012
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial

    Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial von Geert Leroux‐Roels, Arnaud Marchant, Jack Lévy, Pierre Van Damme, Tino F. Schwarz, Yves Horsmans, Wolfgang Jilg, Peter G. Kremsner, Edwige Haelterman, Frédéric Clément, Julian Gabor, Meral Esen, Annick Hens, Isabelle Carletti, Laurence Fissette, Fernanda Tavares Da Silva, Wivine Burny, Michel Janssens, Philippe Moris, Arnaud M. Didierlaurent, Robbert van der Most, Nathalie Garçon, Pascale Van Belle, Marcelle Van Mechelen

    Veröffentlicht 2016
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: